US Stock Insider Trading | Roivant Sciences disclosed three insider trading transactions on February 11

2026-02-22 17:43:20

On February 11, 2026, Roivant Sciences (ROIV) disclosed three insider transactions. Director Sukhatme Mayukh purchased 651,600 shares on February 9, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 11, 2026	Director	Sukhatme Mayukh	February 9, 2026	Sell	651,600	26.47	17,246,700
February 11, 2026	Director	Sukhatme Mayukh	February 9, 2026	Buy	651,600	12.68	8,261,800
January 22, 2026	Director	Epperly Melissa B, MOMTAZEE JAMES C, Oren Ilan	January 20, 2026	Sell	300	22.98	6,894.00
January 14, 2026	Executive	Venker Eric	January 12, 2026	Buy	200,000	3.85	770,000
January 14, 2026	Executive	Venker Eric	January 12, 2026	Sell	200,000	21.92	4,384,000
December 31, 2025	Director	Sukhatme Mayukh	December 31, 2025	Buy	3,198,200	12.68	40,553,600
December 31, 2025	Director	Sukhatme Mayukh	December 29, 2025	Sell	748,400	21.74	16,269,300
December 31, 2025	Director	Sukhatme Mayukh	December 31, 2025	Sell	2,449,900	21.71	53,186,800
December 29, 2025	Executive	Venker Eric	December 23, 2025	Sell	200,000	22.45	4,490,000
December 29, 2025	Executive	Venker Eric	December 24, 2025	Buy	431,700	3.85	1,662,000

[Company Information]

Roivant Sciences Ltd. is a company incorporated in Bermuda on July 6, 2020. Roivant’s mission is to improve healthcare for patients by viewing every inefficiency as an opportunity. Roivant accelerates the development of transformative drugs by creatively building technology and cultivating talent, leveraging the Roivant platform to launch “Vants”—agile and focused biopharmaceutical and health technology companies.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes